Burning Rock Biotech Ltd (BNR) Cash Flow

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-8.53%-6.22M

41.00%-3.27M

218.49%2.63M

37.26%-4.17M

47.47%-5.73M

65.29%-5.55M

77.49%-2.22M

65.25%-6.64M

31.20%-10.91M

26.14%-15.98M

44.19%-9.85M

8.52%-19.12M

13.89%-15.86M

-22.59%-21.64M

-26.40%-17.65M

-270.08%-20.90M

-105.65%-18.42M

-148.19%-17.65M

-97.19%-13.96M

---5.65M

--325.99M

18.74%36.63M

-59.35%-7.08M

--30.85M

---4.44M

Net income from continuing operations

----

-214.07%-7.42M

-71.18%-13.43M

---2.36M

---7.85M

Operating gains losses

----

3.89%1.09M

52.80%1.25M

--1.05M

--816.67K

Other non-cash items

----

-19.78%38.14M

-2.61%379.48K

--47.54M

--389.64K

Change in working capital

----

130.08%4.71M

19.35%2.34M

---15.64M

--1.96M

-Change in receivables

----

161.64%6.70M

-422.05%-1.17M

---10.86M

--362.88K

-Change in inventory

----

-20.69%-151.96K

77.51%-250.82K

---125.91K

---1.12M

-Change in prepaid expenses

----

-340.71%-343.61K

-105.79%-149.14K

--142.75K

--2.57M

-Change in other current assets

----

-106.77%-8.19K

-49.44%-492.74K

--120.99K

---329.72K

-Change in other current liabilities

----

106.28%225.82K

1012.21%1.11M

---3.59M

---122.03K

Cash from non-recurring investing activities

Cash from operating activities

-8.53%-6.22M

41.00%-3.27M

218.49%2.63M

37.26%-4.17M

47.47%-5.73M

65.29%-5.55M

77.49%-2.22M

65.25%-6.64M

31.20%-10.91M

26.14%-15.98M

44.19%-9.85M

8.52%-19.12M

13.89%-15.86M

-22.59%-21.64M

-26.40%-17.65M

-270.08%-20.90M

-105.65%-18.42M

-148.19%-17.65M

-97.19%-13.96M

---5.65M

--325.99M

18.74%36.63M

-59.35%-7.08M

--30.85M

---4.44M

Investing cash flow

Net cash from continuing investing activities

----

-46.81%510.25K

30.02%1.14M

--959.29K

--873.83K

Capital expenditures

----

-46.87%510.25K

29.98%1.14M

--960.33K

--874.12K

Net cash flow from disposal of fixed assets

----

-46.06%510.25K

29.73%1.13M

--945.88K

--873.83K

Net cash flow from intangible asset transactions

----

-100.00%0.00

--2.54K

--13.41K

--0.00

Net cash flow from investment products

----

100.00%0.00

--4.28M

---25.08M

--0.00

Cash from non-current investing activities

Net cash flow from investing activities

191.13%29.04K

35.30%-212.98K

-146.51%-111.89K

51.15%-135.89K

92.10%-31.86K

42.59%-329.15K

93.80%-45.39K

90.22%-278.17K

-109.04%-403.41K

70.60%-573.37K

93.04%-732.13K

74.82%-2.84M

142.64%4.46M

-104.34%-1.95M

-87.52%-10.52M

79.72%-11.29M

-124.52%-10.46M

8915.45%44.98M

-278.44%-5.61M

---55.69M

--42.66M

98.04%-510.25K

459.80%3.14M

---26.04M

---873.83K

Financing cash flow

Cash flow from continuous financing activities

--280.54K

--0.00

96.14%-10.20K

100.00%275.36

100.00%0.00

81.97%-264.18K

-1605.71%-6.43M

98.63%-138.19K

99.23%-4.52K

-37.59%-1.47M

92.71%-377.00K

-627.95%-10.10M

9.18%-589.67K

-110.10%-1.07M

-61.98%-5.17M

-100.52%-1.39M

-101.69%-649.30K

6738.26%10.55M

---3.19M

--265.94M

-56.30%38.45M

-94.68%154.22K

--87.98M

--2.90M

Net cash flow from debt Issuance/repayment

----

137.62%318.75K

-103.89%-121.17K

---847.39K

--3.12M

Net cash flow from common stock issuance/repurchase

----

---513.50K

----

Net cash flow from preferred stock issuance/repurchase

----

-57.08%38.13M

917.98%1.78M

--88.83M

---218.17K

Net cash flow from other financing activities

----

---995.65K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

--280.54K

--0.00

96.14%-10.20K

100.00%275.36

100.00%0.00

81.97%-264.18K

-1605.71%-6.43M

98.63%-138.19K

99.23%-4.52K

-37.59%-1.47M

92.71%-377.00K

-627.95%-10.10M

9.18%-589.67K

-110.10%-1.07M

-61.98%-5.17M

-100.52%-1.39M

-101.69%-649.30K

6738.26%10.55M

---3.19M

--265.94M

-56.30%38.45M

-94.68%154.22K

--87.98M

--2.90M

Net cash flow

Beginning cash balance

-13.20%69.77M

-14.41%72.64M

-22.08%68.66M

-28.58%73.39M

-27.36%80.38M

-35.07%84.87M

-40.26%88.12M

-36.86%102.76M

-40.21%110.65M

-39.41%130.70M

-43.08%147.50M

-44.84%162.75M

-43.42%185.06M

-28.18%215.71M

-18.39%259.14M

-24.56%295.07M

522.74%327.05M

2064.69%300.34M

1694.65%317.54M

--391.15M

--52.52M

-2.33%13.87M

10.19%17.69M

--14.21M

--16.06M

Current period cash flow changes

-6.88%-5.94M

41.32%-3.44M

210.59%3.30M

64.58%-4.79M

42.21%-5.56M

65.98%-5.87M

76.92%-2.98M

31.07%-13.53M

45.57%-9.63M

29.92%-17.25M

60.98%-12.91M

46.37%-19.63M

50.25%-17.68M

-184.08%-24.62M

-57.23%-33.08M

52.40%-36.59M

-111.21%-35.54M

-22.15%29.28M

-450.99%-21.04M

---76.88M

--317.19M

-19.24%37.61M

-74.28%-3.82M

--46.57M

---2.19M

Effect of exchange rate changes

-116.70%-33.66K

474.59%42.01K

274.39%790.83K

-180.47%-486.98K

-88.98%201.56K

101.06%7.31K

47.37%-453.49K

-106.39%-173.63K

-52.07%1.83M

-57.29%-691.04K

77.61%-861.59K

252.39%2.72M

172.30%3.81M

-116.91%-439.33K

67.97%-3.85M

106.24%770.71K

-2362.83%-5.28M

296.49%2.60M

-32873.94%-12.01M

---12.35M

---214.23K

84.74%655.43K

-115.96%-36.44K

--354.78K

--228.35K

Ending cash balance

-14.69%63.83M

-12.41%69.19M

-15.48%71.95M

-23.12%68.60M

-25.94%74.82M

-30.37%79.00M

-36.75%85.14M

-37.65%89.23M

-39.64%101.03M

-40.63%113.45M

-40.46%134.59M

-44.63%143.12M

-42.58%167.38M

-42.03%191.09M

-23.76%226.06M

-17.75%258.48M

-21.15%291.51M

540.25%329.62M

2036.95%296.50M

--314.26M

--369.71M

-15.29%51.48M

0.06%13.87M

--60.77M

--13.87M

Free cash flow

----

20.85%36.12M

-54.52%-8.22M

--29.89M

---5.32M

Currency unit

USD

Audit opinions

--

Burning Rock Biotech Ltd

Statements

Income Statement

Balance Sheet

Cash Flow Statement